ArticleTranslational lung cancer research2022
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance.
Chuanfen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it